Back to Research Hub
Biohaven Ltd.
BHVN
$11.93+0.81 (+7.24%)
Biohaven Ltd. is a clinical-stage biopharmaceutical company. The Company focuses on development of therapies for neurological and immunoscience diseases that can change current treatment paradigms.
StreetsValue research for Biohaven Ltd. (BHVN)
Members get the full report for Biohaven Ltd.: a fair value estimate and valuation analysis, economic moat rating, growth and profitability factor grades, a bull and bear investment thesis, analyst price targets, insider and congressional trading activity, and which super investors own the stock.